Uncategorized

Bristol Myers Stock Jumps. Why FDA Approval for Schizophrenia Drug Is Groundbreaking. – Barron’s

Posted on Author Comments Off on Bristol Myers Stock Jumps. Why FDA Approval for Schizophrenia Drug Is Groundbreaking. – Barron’s

Bristol Myers Stock Jumps. Why FDA Approval for Schizophrenia Drug Is Groundbreaking.  Barron’sF.D.A. Approves the First New Schizophrenia Drug in Decades  The New York TimesFDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades  CNBCRevolutionary drug for schizophrenia wins US approval  Nature.comFDA approves a novel drug for schizophrenia, a potential ‘game changer’  The Washington Post